Vista Pharmaceuticals Ltd.
Snapshot View

6.98 +0.18 ▲2.7%

16 August 2022, 03:31:00 PM
Volume: 4,970

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vistapharmaceuticals.com
Market Cap 24.91 Cr.
Enterprise Value(EV) 41.90 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -0.23 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 9.64 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.70 Calculated using Price: 6.77
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 3.68 Cr. 36,793,908 Shares
FaceValue 2
Company Profile
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.65%
1 Week
+3.41%
1 Month
+3.87%
3 Month
-1.41%
6 Month
-38.77%
1 Year
-24.62%
2 Year
-26.53%
5 Year
-75.42%
10 Year
+1.45%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 0.94 5.27 13.94 7.15 8.97 10.19 3.15 -11.68 -6.03
Return on Capital Employed (%) 2.06 5.38 14.16 9.57 8.92 12.42 6.28 -5.20 -4.60
Return on Assets (%) 0.55 3.27 7.39 3.15 3.70 4.67 1.78 -7.11 -3.65

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 9 9 10 11 17 32 36 30 33 35
Non Curr. Liab. 0 0 0 8 5 6 6 5 11 13
Curr. Liab. 6 5 12 7 19 15 11 16 9 4
Minority Int.
Equity & Liab. 14 14 23 26 41 53 53 51 53 52
Non Curr. Assets 13 12 11 10 16 25 29 30 37 37
Curr. Assets 2 2 12 16 26 28 23 21 15 15
Misc. Exp. not W/O
Total Assets 14 14 23 26 41 53 53 51 53 52

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 7 8 14 15 24 29 31 23 1 0
Other Income 0 0 0 0 0 0 3 4 0 0
Total Income 7 8 14 15 24 29 34 27 2 1
Total Expenditure -7 -7 -11 -13 -21 -24 -30 -28 -3 -2
PBIDT 1 1 3 3 3 6 4 -1 -1 -1
Interest 0 0 -1 -1 -2 -2 -2 -2 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 -1 0 0 2 2
Exceptional Items
PAT 0 0 1 1 1 2 1 -4 -2 -1
Adjusted EPS 0 0 1 0 0 1 0 -1 -1 0

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -4 -3 3 -5 3 1 -7
Cash Fr. Inv. 0 0 0 0 0 -4 -11 -6 -2 0
Cash Fr. Finan. 0 0 4 3 6 11 1 0 7
Net Change 0 0 0 0 5 -4 -1 -1 0
Cash & Cash Eqvt 0 0 0 0 0 6 2 1 0 0

Shareholding Pattern View Details >>

9 Qtrs 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%)
Promoter 38.14 38.14 38.14 31.48 31.48 35.29 35.29 36.94 36.94
Public 61.86 61.86 61.86 68.52 68.52 64.71 64.71 63.06 63.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 13 Aug 2022
Board Meeting Outcome for OUTCOME OF BOARD MEETING
With reference to the subject cited it is hereby informed that the Board of Directors of the Company at its Meeting held on Saturday 13th August 2022 at 3:00 PM at the corporate office of the Company inter-alia considered and approved the following:1. Un-Audited Financial Results for the quarter ended 30th June 2022.2. Limited Review Report for the quarter ended 30th June 2022.3. Draft Board of Directors Report on the companys activities for the financial year ended March 31st 2022.4. To convene the Annual General Meeting of the company for the financial year 2021-22.5. Draft Notice for the Annual General Meeting of the Members of the Company.6. Appointment of Mr. NVSS Suryanarayana Rao Practicing Company Secretary as Scrutinizer for E-voting at the ensuing Annual General Meeting.Kindly take the same on record and acknowledge the receipt of the same.
Sat, 13 Aug 2022
FINANCIAL RESULTS FOR QUARTER ENDED 30TH JUNE 2022
With reference to the subject cited it is hereby informed that the Board of Directors of the Company at its meeting held on Saturday 13th August 2022 at 3.00 P.M. at the Corporate office of the Company interalia considered and approved the unaudited Financial Results for the quarter ended 30th June 2022.Copy of un-audited Financial Results for the quarter ended 30th June 2022 and Limited review Report is enclosed herewith.Kindly take the same on record and acknowledge the receipt of the same.
Fri, 05 Aug 2022
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.08.2022
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve With reference to the subject cited the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Friday 13.08.2022 at 03.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70 1st Floor Plot No. 85 Shivbagh Ameerpet Hyderabad- 500016 Telangana inter-alia to discuss the following:1. To consider approve and take on record the un-audited Financial Results of the company for the quarter ended 30th June 2022.2. To consider and take note of Limited Review Report for the quarter ended 30th June 2022.3. To consider and approve the Board of Directors report for the financial year 2021-22.4. To fix time date and mode of Annual General meeting.5. Any other items with permission of chairman.

Technical Scans View Details >>

Fri, 12 Aug 2022
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,573.70 +2.2%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Vista Pharmaceuticals Ltd.

Can I Buy Vista Pharma Shares now?

What is the Share Price of Vista Pharma?

What is the Relative Strength Index (RSI) Value of Vista Pharma?

What is the Market Capital (MCAP) of Vista Pharma?

What are the key metrics to analyse Vista Pharma?

What is the Price Performance of Vista Pharma?